Removal of a partial genomic duplication restores synaptic transmission and behavior in the MyosinVA mutant mouse Flailer.
Fernando Jose BustosSwarna PandianHenny HaensgenJian-Ping ZhaoHaley StroufMatthias HeidenreichLukasz SwiechBenjamin E DevermanViviana GradinaruFeng ZhangMartha Constantine-PatonPublished in: BMC biology (2023)
Our results demonstrate the potential of DN-CRISPR to efficiently remove larger genomic duplications, working as a new gene therapy approach for treating neurodegenerative diseases.